Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro

Nutrition and Cancer

Volumn 35, Issue 1, 1999, Pages 80-86

  Lyn Cook, Beverly D ^a   Rogers, Themeka ^b   Yan, Yan ^a   Blann, Ernice B ^a   Kadlubar, Fred F ^a   Hammons, George J ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b TUSKEGEE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; POLYPHENOL; RIBOFLAVIN DERIVATIVE; RNA;

ARTICLE; CANCER INHIBITION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PANCREAS TUMOR; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEA;

EID: 0032762646     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S1532791480-86     Document Type: Article

References (44)

1. Graham, HN: Green tea composition, consumption, and polyphenol chemistry. Prev Med 21, 334-350, 1992.
2. Ho, CT, Chen, Q, Shi, H, Zhang, KQ, and Rosen, RT: Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev Med 21, 520-525, 1992.
3. Katiyar, SK, and Mukhtar, H: Tea in chemoprevenlion of cancer: epidemiological and experimental studies (review). Int J Oncol 8, 221-238, 1996.
4. Balentine, DA: Manufacturing and chemistry of tea. In Phenolic Compounds in Food and Their Effects on Health, MT Huang, CT Ho, and CY Lee (eds). Washington, DC, Am Chem Soc, 1992, pp 103-117.
5. Weisburger, JH: Tea and health: a historical perspective. Cancer Lett 114, 315-317, 1997.
6. Kohlmeier, L, Weterings, KG, Steck, S, and Kok, FJ: Tea and cancer prevention: an evaluation of epidemiologic literature. Nutr Res 27, 1-13, 1997.
7. Chen, YT, Zheng, RI, Jin, ZJ, and Ju, Y: Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med 9, 19-21, 1990.
8. Stoner, GD, and Mukhtar, H: Polyphenols as cancer chemopreventive agents. J Cell Biochem 22, 169-180, 1995.
9. Yang, G, Liu, Z, Seril, DN, Liao, J, Ding, W, et al.: Black tea constituents, theaflavins, inhibit 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/S mice. Carcinogenesis 18, 2361-2365, 1997.
10. Dreosti, IE, Wargovich, MJ, and Yang, CS: Inhibition of carcinogenesis by tea: the evidence from experimental studies. Crit Rev Food Sci Nutr 37, 761-770, 1997.
11. Weisburger, JH: Tea antioxidants and health. In Handbook of Antioxidation, E Cadenas and L Packer (eds). New York: Dekker, 1996, pp 469-486.
12. Hertog, MGL, Sweetnam, PM, Fehily, AM, Elwood, PC, and Kromhout, D: Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 65, 1489-1494, 1997.
13. Brandi, ML: Flavonoids: biochemical effects and therapeutic applications. Bone Miner 19, S3-S14, 1992.
14. Bu-Abbas, A, Clifford, MN, Walker, R, and Ioannides, C: Marked antimutagenic potential of aqueous green tea extracts: mechanism of action. Mutagenesis 9, 325-331, 1994.
15. Stavric, B, Matula, TI, Klassen, R, and Downie, RH: The effect of teas on the in vitro mutagenic potential of heterocyclic aromatic amines. Food Chem Toxicol 34, 515-523, 1996.
16. Bushman, JL: Green tea and cancer in humans: a review of the literature. Nutr Cancer 33, 151-159, 1998.
17. Weisburger, JH, Rivenson, A, Garr, K, and Aliaga, C: Tea, or tea and milk, inhibit mammary gland and colon carcinogenesis in rats. Cancer Lett 114, 323-327, 1997.
18. Wang, ZY, Huang, MT, Ferraro, T, Wong, CQ, Lou, YR, et al.: Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res 52, 1162-1165, 1992.
19. Conney, AH, Lou, Y-R, Xie, J-G, Osawa, T, Newmark, HL, et al.: Some perspective on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc Soc Exp Biol Med 216, 234-244, 1997.
20. Ji, BT, Chow, WH, Hsing, AW, McLaughlin, JK, Dai, Q, et al.: Green tea consumption and risk of pancreatic and coloreclal cancers. Int J Cancer 70, 255-260, 1997.
21. Fujiki, H, Suganuma, M, Okabe, S, Komori, A, Sueoka, E, et al.: Japanese green tea as a cancer preventive in humans. Nutr Rev 54, S67-S70, 1996.
22. Lu, Y, Lou, Y, Xie, J, Yen, P, Huang, M, et al.: Inhibitory effect of black tea on the growth of established skin tumors in mice: effects on tumor size, apoptosis, mitosis and bromodeoxyuridine incorporation into DNA. Carcinogenesis 18, 2163-2169, 1997.
23. Hibasami, H, Achinea, Y, Fujikawa, J, and Komiya, T: Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anticancer Res 16, 1943-1950, 1996.
24. Yu, R, Jias, JJ, Duk, JL, Gudehithlu, K, Tan, TH, et al.: Activation of mitogen-activated protein kinases by green tea polyphenols: potential signalling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. Carcinogenesis 18, 451-456, 1997.
25. Halder, J, and Bhaduri, AN: Protective role of black tea against oxidative damage of human red blood cells. Biochem Biophys Res Commun 244, 903-907, 1998.
26. Lee, LL, Yamamoto, S, Wanibuchi, H, Wada, S, Sugimura, K, et al.: Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation. Cancer Res 57, 4765-4776, 1997.
27. Yu, D, Liu, B, Jing, T, Sun, D, Price, JE, et al.: Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol. Oncogene 16, 2087-2094, 1998.
28. Tabata, T, Fujimori, T, Maeda, S, Yamamoto, M, and Saitoh, Y: The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 14, 237-244, 1993.
29. Almoguera, C, Shibata, D, Forrester, K, Martin, J, Arnheim, N, et al.: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549-554, 1988.
30. Watanabe, H, Miyagi, C, Yamaguchi, Y, Satomura, Y, Ohta, H, et al.: Detection of K-ras point mutations at codon 12 in pancreatic juice for the diagnosis of pancreatic cancer by hybridization protection assay: a simple method for the determination of the types of point mutations. Jpn J Cancer Res 87, 466-474, 1996.
31. Rivera, JA, Rall, CJ, Graeme-Cooke, F, Fernandez-del Castillo, C, Shu, P, et al.: Analysis of K-ras oncogene mutations in chronic pancreatitis with ductual hyperplasia. Surgery 121, 42-49, 1997.
32. Bosch, I, and Croop, J: P-glycoprotein multidrug resistance and cancer. Biochim Biophys Acta 1288, F37-F57, 1996.
33. Faber, E: Cellular biochemistry of the stepwise development of cancer with chemicals. Cancer Res 44, 5563-5574, 1984.
34. Regine, WF, John, WJ, and Mohiuddin, M: Adjuvant therapy for pancreatic cancer: current status. Front Biosci 3, 186-192, 1998.
35. Ley, RD, and Reeve, VE: Chemoprevention of ultraviolet radiation-induced skin cancer. Environ Health Perspect 4, 981-984, 1997.
36. Parshad, R, Sanford, KK, Price, FM, Steel, VE, Tarone, RE, et al.: Protective action of plant polyphenols on radiation-induced chromatid breaks in cultured human cells. Anticancer Res 18, 3263-3266, 1998.
37. Grinberg, LN, Newmark, H, Kitrossky, N, Rahamim, E, Chevion, M, et al.: Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharmacol 54, 973-978, 1997.
38. Barbacid, M: ras Genes. Annu Rev Biochem 56, 779-827, 1987.
39. Qian, Y, Sebti, SM, and Hamilton, AD: Farnesyltransferase as a target for anticancer drug design. Biopolymers 43, 25-41, 1997.
40. Kelloff, GJ, Lubet, RA, Fay, JR, Steele, VE, Boone, CW, et al.: Farnesyl protein transferase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev 6, 267-282, 1997.
41. Casey, PJ, Solski, PA, Der, CJ, and Buss, JE: p21 ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 86, 8323-8327, 1989.
42. Vann Waardenburg, RCAM, Prins, J, Meijer, C, Uges, DRA, De Vries, EGE, et al.: Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines. Anticancer Res 16, 1963-1970, 1996.
43. Paschka, AG, Bulter, R, and Young, CY: Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 130, 1-7, 1998.
44. Regine, WF, John, WJ, and Mohiuddin, M: Adjuvant therapy for pancreatic cancer: current status. Front Biosci 3, 186-192, 1998.